nd ESTRO Forum 2013 S223 deviation. Within each BH, the set-up remained stable within 1.0 mm. EPID images showed that σ intra was 1.4 mm in both u-and v-directions, increasing the σ total by about 0.5 mm (depending on the value of σ inter ). σ inter was 1.2 and 1.7 mm with online CBCT protocol, but recalculated to be 2.3 and 2.7 mm in case of set-up on laser marks only. Without protocol, Σ u would have been 3.3 mm and Σ v 2.7 mm; with an online CBCT protocol this reduced to 1.2 (u) and 1.4 (v) mm. Because many patients changed their BH pattern during or after the first week of treatment, both the offline NAL and weekly eNAL protocols were less effective, indicating that more intensive imaging protocols have to be applied. CTV-PTV margins can be reduced from 10 mm (no protocol) to 7 mm with a weekly eNAL protocol, 5 mm with a daily eNAL protocol, or 4 mm with an online protocol. Conclusions: For accurate radiotherapy breast treatments using a voluntary DIBH technique a daily imaging protocol is required. Although CBCT provides full information about patient positioning and is needed for a 3D treatment beam setup, imaging of the mediolateral beam can be a fair alternative for treatments with tangential beams only, resulting in a decrease of patient dose. Purpose/Objective: To explore the potential of scanned helium ion beams compared to scanned proton beam therapy in a treatment planning study. The physical characteristics of helium ions (different peak to plateau ratio and sharper beam penumbra) seem to make it a promising candidate for radiation oncology. Materials and Methods: All treatment plans were created with the treatment planning system Hyperion, utilizing a novel pencil beam algorithm for both proton and helium ion beams. Employing the same conceptual dose calculation algorithm for both ions enables a precise comparison without having to account for deviations within algorithms. Sample treatment plans were calculated for prostate cases and skull base tumours. For both scenarios two laterally opposed beams were applied. Treatment plan optimisation was done with the same algorithm, constraints and scanning pattern for a given treatment site for both particle species. Prostate patients received 78 Gy to the PTV, defined as the CTV with an isotropic 5mm margin. For the prostate plans two organs at risk (rectum and bladder) were delineated. The skull base patients were prescribed 54 Gy to the PTV, delineated using the CTV plus a 3mm isotropic margin. For the skull base plans five organs at risk (eyes, optic nerves and brainstem) were delineated. Results were evaluated using dose volume histograms (DVH) and target coverage and conformity. Results: Two prostate patients have been evaluated so far (PTV volumes ~126 ccm). D median for both patients was 78.7 ± 0.4 Gy. D 2% for prostate patient 1 was 80.1 vs 79.8 Gy with a V 95% of 98.6 vs 99.2 % for protons and helium ions, respectively. Corresponding values for patient 2 were similar (D 2% of 80.5 vs 79.8 Gy with a V 95% of 98.7 vs 99.2 % for protons or helium ions). The conformity index for patient 1 was 0.06 vs 0.04 for protons and helium ions, for patient 2 0.07 vs 0.04. For the skull base patient 1 (average PTV 81.7 ccm) PTV D median was 54.3 ± 0.1 Gy for both particles. D 2% was 56.2 vs 55.6 Gy with a V 95% of 96.1 vs 98.6 % for protons and helium ions, respectively. Corresponding values for patient 2, having a smaller PTV (volume of 30.9 cm), were: D 2% 55.8 vs 55.4 Gy with a V 95% of 97.6 vs 99.3 % for protons or helium ions. The conformity index for skull base patient 1 was 0.11 vs 0.07, for patient 2 0.09 vs 0.05 for protons and helium ions. Organ at risk doses for both patients did not exceed the tolerance values as specified in the QUANTEC report. Conclusions: Systematically steeper PTV DVH curves were obtained for helium ions, with a reduced D 2% and increasing V 95% . The dosimetric improvements of treatment plan parameters when using helium ions compared to protons motivate a more thorough investigation of helium ions. Current work in progress deals with improvements in RBE modelling of helium ions during optimisation to fine tune the model. Purpose/Objective: Internal target and organ motion during treatment is a challenge in radiotherapy (RT) of the prostate and the involved elective targets, with residual motion being present also following image-guidance strategies. The aim of this study was to investigate organ motion induced dose degradations for the prostate, seminal vesicle and the pelvic lymph node targets when treating these targets with proton therapy, using different image-guidance and delivery strategies. Materials and Methods: Four patients were selected from a larger series as they displayed large inter-fractional variation in bladder and rectum volume. Intensity-modulated proton therapy (IMPT) plans were generated using both simultaneous integrated (SIB) and sequential boost delivery. For each technique, three isotropic margin expansions (in the range of 4-10mm) were evaluated for the clinical target volume of prostate (CTV-p), seminal vesicles (CTV-sv) and lymph nodes (CTV-ln). Simulation of the dose degradations for all treatment plans were based on dose re-calculations for the 8-9 repeat CTs available for each patient, after applying rigid registrations to reproduce set-up based on either intra-prostatic fiducials or bony anatomy. Results: The simulated dose received by 99% of the target volume (D99) and generalized equivalent dose (gEUD) showed substantial inter-patient variations. For 40% of the investigated scenarios, the patient average simulated D99 for all targets were within 2GyE from the planned. The largest difference between simulated and planned dose was seen for the CTV-sv when using SIB delivery, with an average relative reduction in D99 of 13% and 15% for the largest margin expansion, when positioned using fiducials and bony anatomy respectively (Table 1) .
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Conclusions:
The most severe dose degradations were found for the seminal vesicles, but they were also evident for the lymph node target. The degradations could not be completely resolved, neither by using the largest margin expansion nor with the choice of set-up. With fiducial set-up the prostate target was robust against the interfraction changes. Purpose/Objective: To evaluate the correlation between the reference DWH of bladder wall (DWH) outlined by using MRI images and DVH of bladder including filling, dose surface (DSH) and DVH of artificial bladder wall in prostate cancer patients planned both with 3D-conformal and IMRT techniques. Materials and Methods: 27 prostate cancer patients were submitted to CT and MRI scans that were used to draw bladder walls. External bladder surfaces were then used to create artificial bladder walls applying automatic contractions of 5 (DVH5), 7 (DVH7) and 10 mm (DVH10). For each patient a 3DCRT (box technique) and an IMRT (5 fields) treatment plan was generated prescribing at ICRU reference point 77.4 Gy (1.8 Gy/fr) to PTVprostate and 61.2 Gy (1.8 Gy/fr) to PTVprostate+seminal vesicle Gy(1.8Gy/fr). For all the patients the mean difference and standard deviation between the DWH and the other surrogates, both in percentage (%) and absolute volume(cm 3 ), was calculated and considered for the analysis. Correlation was quantified for selected dose-volume/surface parameters by R Spearman correlation coefficient. Results: %DWH was found to be correlated to DVH5, DVH7 and DVH10 (maximum average deviations below 2%, SD<5%) with DVH5 that showed the best agreement. Slightly better correlation was found for absolute (R=0.80-0.94) compared to relative (R = 0.66-0.92) histograms. DSH was also foundto be highly correlated to DWH (maximum difference<2% and 9% for 3DCRT andIMRT, respectively, and R>0.64), although slightly higher deviations were generally found. DVH was not a good surrogate of DWH (R<0.7 for most ofparameters). When comparing the two treatment techniques, Spearman's correlation coefficients were significantly lower for IMRT compared to 3DCRT both in relative (p=0.002) and absolute (p=0.0007) values. Conclusions: DVH of the bladder including filling wasn't a good surrogate of DWH. DSH resulted to be correlated to DWH as well as DVH5,7,10 with slightly better results for absolute compared to relative histograms. As far as treatment planning techniques, Spearman's correlation coefficients for IMRT planning resulted significantly lower compared to 3DCRT. These results suggest to use DVH of the bladder wall obtained by performing automatic 3D contractions of external surface of the bladder inclinical practice. The Johns Hopkins University, Radiotherapy, Baltimore MD, USA Purpose/Objective: The large amount of images taken during image guided/adaptive treatments, increases the possibility to assess the early response of tissues to the treatment. The possibility of early (i.e. during the first weeks of treatment) measuring image-based parameters that may potentially predict the outcome of the treatment in terms of both tumour response and toxicity is of particular interest. Regarding head-and-neck cancer (HNC), parotid glands (PGs) are known to experience large deformation and this may be related to acute toxicity (i.e. xerostomia). The aim of this study is to found image based score parameters that could be useful to early predict final PG variations. Materials and Methods: 92 PGs (46 patients) from two Institutions (group A and B) were analyzed based on CT images acquired during IMRT treatment. Patients were treated with radiotherapy (+ concomitant chemotherapy) to 58.1/70 Gy in 35 fractions (median values, dose of tumor and nodes PTVs), 29 with SIB approach. For all patients, diagnostic kVCT images were acquired at the begin of the treatment and at the end and additional kVCTs were acquired during the treatment, weekly in group A, one at mid-treatment in group B. Image registration was performed between initial CT and the others, using an in home developed non-rigid approach based on free-form deformation (FFD) and B-splines. PG contours, drawn by experts on the initial CT, were automatically propagated to the other images using a previously validated algorithm. PG deformations were described by the rates of density variation (rΔρ [HU/day]), volume variation (rΔvol [mm3/day]) in different parts of treatment. Student t-test, multi-variate logistic (MVA) including ROC curve analysis and assessment of predictive value of the models based on area under the curve (AUC) evaluations were performed. Results: As shown in Figure 1 , PG density and volume rates are larger during the first weeks of treatment, especially for density rate variation r?ρ where it results to be highly significant (group A: -0.495 vs -0.046, p-value=0.0001) . When considering the risk of experiencing a large density or volume change at the end of therapy (defined as a value larger of the quartile of the population), logistic regression indicates that they can be predicted by the changes in the first two weeks with a moderately high predictive value (AUC > 80%). Similar results with a lower predictive value (AUC around 70%) were found when looking to the mid-term changes of A+B groups.
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Conclusions:
The rate of PG volume and density variations is larger at the begin of the treatment; this effect is more pronounced for density changes. Based on the early variations, it is possible to predict with a good approximation the final PG changes. This result may be used to early identify patients which may be subject to larger variations and then possibly selected for adaptive re-planning.
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Automated online MRI-guided adaptive radiotherapy: contour propagation and IMRT re-optimization J.J.E. Kleijnen 1 1 UMC Utrecht, Radiotherapy, Utrecht, The Netherlands Purpose/Objective: The development of the Utrecht design, hybrid 1.5T MRI linear accelerator offers the ability to perform online MRIguided adaptive radiotherapy (ART). This MRI guided ART allows for the creation of an optimal treatment plan on the actual anatomy for every single treatment fraction. Hereby margins can be reduced due to the absence of inter fraction motion and set-up errors. Additionally, MRI's superior soft-tissue contrast allows direct tumor visualization instead of indirect features used on a CT. These features open the possibility for dose escalation. Yet this daily optimization requires a fast automated contour propagation and treatment planning to be feasible in clinical practice. We propose and evaluate an automated workflow for online MRI guided ART for rectal cancer boost therapy. Materials and Methods: Until now, 10 rectal cancer patients (T2-3 N0-1 M0-1) underwent pre-treatment and 3-4 consecutive daily fraction T2 MR scans. Pre-treatment target volumes and OAR were delineated by an experienced radiation oncologist. These contours were then propagated to the 3 or 4 consecutive daily fraction MRI's by deformable image registration (DIR) of the pre-treatment MRI to the fraction MRI. This automated propagation was performed via a multi step approach (consecutive Euler, affine and B-spline transforms) using the Elastix toolkit (Klein 2010). PTV margins between 1 -8 mm in plane and 4 -8 mm out of imaging plane, were then applied to the transformed CTV and GTV. For each margin, a 7 beam IMRT boost treatment plans was made. A dose of 50 Gy was prescribed to the PTV CTV and a total dose of 60 Gy was prescribed to the PTV GTV . For planning, a fast Monte Carlo based IMRT planning system was used (Bol 2012) . The dosimetric evaluation of the treatment plans was done on golden standard contours. These are obtained by manual correction and approval by radiation oncologist of the propagated contours. D 99% of the gold standard CTV and GTV were evaluated. When a D 99%
